Skip to main content / 跳转到主要内容

International Healthcare Pricing Data

1,954 procedures. 70+ countries. Real prices from JCI or equivalent nationally accredited providers, paired with US cost estimates built on Medicare data and 293 verified overrides.

1,954 Procedures70+ Countries293 Verified US Price OverridesUpdated Quarterly

The Dataset

Sylk Health maintains the only pricing dataset that pairs real international provider prices with a statistically modelled US cost baseline across nearly 2,000 medical procedures. Every international price comes from a JCI or equivalent nationally accredited facility. Every US estimate is built from the v7.1 Medicare-to-cash pricing model, anchored by 293 independently verified override prices.

FieldCoverage
Procedure name (standardised)All 1,954
CPT/ICD crosswalkAll 1,954
US cash-price estimate (v7.1)All 1,954
US verified override price293 procedures
International provider priceVaries by country
Provider accreditation statusAll international entries
Country and cityAll international entries
Currency + USD conversionAll international entries
Last price update dateAll entries

Who Uses This Data

📊

Actuaries & Underwriters

Rate-setting for international benefits, stop-loss reserves, and plan pricing models that account for cross-border cost differentials.

📋

Benefits Consultants

Client advisory backed by real pricing. International benchmarking for plan design recommendations and annual reviews.

⚙️

TPAs & Claims Administrators

Reference rates for international claims adjudication. Validate provider invoices against market pricing.

🛡️

Stop-Loss Carriers

Underwrite medical travel riders with actual cost data. Price policies covering international procedures using verified facility-level pricing.

⚖️

Law Firms (ERISA)

Independent pricing benchmarks for plaintiff and defense. Methodology-attested data suitable for expert reports and Daubert scrutiny.

🔬

Researchers & AI

Health economics research, policy analysis, AI training data, and academic publication. Documented methodology with known error rates.

Pricing

Published pricing. No sales call required for tiers 1-3.

Free Sample

$0

Top 20 procedures, US vs. international medians, methodology overview. PDF, email required.

Download Free Report

Standard Annual

$2,500/yr

Full 1,954-procedure catalogue. PDF + Excel. Single user. Quarterly updates.

Professional: $5,000/yr (3 users, +CSV)

Firm: $7,500/yr (unlimited users)

Purchase License

Enterprise

$25K-75K/yr

API access (JSON). Custom queries. Snowflake delivery. Quarterly trend reports. Dedicated support.

Request API Access

Custom

$15K-50K

Bespoke analysis. Litigation packages. Expert witness support. White-label licensing.

Request Access

Coverage Preview

Data availability by procedure category. Counts are approximate and updated quarterly.

CategoryProceduresCountries
Orthopaedic (Joint, Spine)18742
Cardiac (CABG, Valve)13438
Oncology (Surgical, Radiation)24631
Bariatric (Bypass, Sleeve)2847
Ophthalmology (Cataract, LASIK)8944
Dental (Implants, Crowns)15652
Fertility (IVF, Egg Freezing)6739
Cosmetic (Rhinoplasty)11251
Urology9829
Gynaecology8433
Neurology (Spinal Fusion, DBS)7326
Gastroenterology9141
Transplant4218
Diagnostic (MRI, CT, PET)20348
Rehabilitation11835
Other Surgical/Medical22637

How the Data Is Built

US Pricing (v7.1 Model)

  1. 1Override table (293 procedures): Independently verified cash prices. 0% estimation error.
  2. 2Formula tier: Medicare-to-cash multiplier model. ~21% median error.
  3. 3Residual correction: 60-tree gradient-boosted model reducing systematic bias.

International Pricing

Collected directly from providers holding JCI or equivalent nationally recognised accreditation. Each entry includes facility name, accreditation body, procedure definition (CPT/ICD mapped), quoted currency with USD conversion, and date last confirmed.

Sylk Health doesn't estimate international prices. Every international data point is a real published price from a real facility.

Why This Data

Independence

Not affiliated with any hospital, insurer, TPA, or provider network. Both plaintiff and defense attorneys cite the same data.

Methodology Transparency

Fully documented with known error rates, testable assumptions, and reproducible outputs. White paper available on request.

Minimal Data Footprint

Aggregate facility-level pricing only. No patient information, no claims data, no member rosters, no identifiable health information.

Academic Citation

Structured for publication and citation. Reduced-rate researcher access generates published validation of the pricing models.

ERISA Litigation Support

155 ERISA fiduciary lawsuits were filed in 2025. 35 targeted health plans. The Supreme Court's decision in Cunningham v. Cornell shifted the evidentiary burden to defendants, making pricing benchmarks essential for both sides.

Plaintiff Firms

Independent US cash-price benchmarks and international comparators for procedures at issue. Methodology attestation for expert reports. Per-case packages from $15,000.

Defense Firms

Percentile positioning showing where plan pricing falls relative to verified market rates. Independent third-party sourcing eliminates conflict-of-interest vulnerabilities. Annual subscriptions from $30,000.

Sylk Health provides factual pricing data. It doesn't constitute legal advice, and data licensing to one party in litigation doesn't preclude licensing to any other party. The dataset is a benchmark, not advocacy.

Frequently Asked Questions

Ready to access the data?

Download the free sample report or request enterprise access.

Pricing data is provided for informational and analytical purposes only. It doesn't constitute medical advice, treatment recommendations, or guarantees of pricing at any specific facility. US price estimates are derived from statistical models with documented error rates. International prices reflect provider-published rates at time of collection and may change. Data licensing terms prohibit redistribution without license, use in direct-to-consumer marketing lists, and automated bulk scraping. Current as of April 2026.